The lead article, Poly(ADP-ribosylation) - PARP in DNA Repair and Apoptosis, describes the structure and function of human PARP, which is a major target for drugs being designed to treat a number of diseases, such as cancer, diabetes, inflammation, and retroviral infection.
This issue contains the following groups of products:
- 15 Antibodies for DNA Damage and Repair
- 10 PARP Inhibitors and the PARP Cleavage Detection Kit
- DNA-Dependent Protein Kinase (DNA-PK) Inhibitors
- Antibodies for DNA-Dependent Protein Kinases
- p21-Acitvated Kinase Inhibitor and Negative Control
- 4 Apoptosis Activators
- Viral Proteases
- Kits for Apoptosis Research
- 5 Pifithrins: Inhibitors of p53 Action
- 8 Protein Kinase Inhibitors
- Inhibitors of Akt/PI-3 Kinase Signaling
- ERK Inhibitors
- 13 Recombinant Protein Tyrosine Kinases
- 6 Products in the Neurochemical Corner
- Inhibitors of Angiogenesis
- 4 Receptor Tyrosine Kinases and 4 PhosphoDetect Antibodies for Angiogenesis Research
- 5 Proteasome/Ubiquitination Reasearch Products
| |
